Consumer Mobile Apps for Potential Drug-Drug Interaction Check: Systematic Review and Content Analysis Using the Mobile App Rating Scale (MARS).
Consumer Mobile Apps for Potential Drug-Drug Interaction Check: Systematic Review and Content Analysis Using the Mobile App Rating Scale (MARS).
复制标题
DOI：
10.2196/mhealth.8613
复制
发表时间：
2018-03-28
影响因子：
5
通讯作者：
Lee J
中科院分区：
文献类型：
--
作者：
Kim BY;Sharafoddini A;Tran N;Wen EY;Lee J
普通消费者现在可以通过移动健康（mHealth）应用程序轻松访问药物信息并快速检查潜在的药物-药物相互作用（pddi）。随着加拿大人口老龄化，越来越多的人患有慢性疾病和合并症，导致药物数量增加。使用移动健康应用程序检查pddi有助于确保患者安全和赋权。本研究的目的是回顾检查pddi的公开可用移动健康应用程序的特征和质量。通过搜索Apple App Store和b谷歌Play来识别具有PDDI功能的应用。提取了应用程序的一般特征和特征特征。采用移动应用评级量表（MARS）对质量进行评估。共有23款应用被纳入评测范围，其中12款来自苹果App Store， 11款来自b谷歌Play。其中只有5款是付费应用，平均价格为7.19加元。MARS平均评分为3.23分（四分位数差为1.34分）。b谷歌Play和Apple App Store应用的平均MARS分数无统计学差异（P= 0.84）。信息维度的得分最高（3.63），而敬业维度的得分最低（2.75）。每个应用的功能总数、平均评分和价格与MARS总分显著相关。一些应用程序提供了关于pddi潜在不良药物影响的准确和全面的信息。鉴于不正确的药品信息可能造成的严重后果，有必要进行监督，以消除低质量和潜在有害的应用程序。由于在缺乏完整信息的情况下管理PDDI非常复杂，因此诸如用药提醒、续药提醒、用药历史跟踪和药丸识别等次要功能可以帮助提高PDDI应用程序的有效性。
General consumers can now easily access drug information and quickly check for potential drug-drug interactions (PDDIs) through mobile health (mHealth) apps. With aging population in Canada, more people have chronic diseases and comorbidities leading to increasing numbers of medications. The use of mHealth apps for checking PDDIs can be helpful in ensuring patient safety and empowerment. The aim of this study was to review the characteristics and quality of publicly available mHealth apps that check for PDDIs. Apple App Store and Google Play were searched to identify apps with PDDI functionality. The apps’ general and feature characteristics were extracted. The Mobile App Rating Scale (MARS) was used to assess the quality. A total of 23 apps were included for the review—12 from Apple App Store and 11 from Google Play. Only 5 of these were paid apps, with an average price of $7.19 CAD. The mean MARS score was 3.23 out of 5 (interquartile range 1.34). The mean MARS scores for the apps from Google Play and Apple App Store were not statistically different (P=.84). The information dimension was associated with the highest score (3.63), whereas the engagement dimension resulted in the lowest score (2.75). The total number of features per app, average rating, and price were significantly associated with the total MARS score. Some apps provided accurate and comprehensive information about potential adverse drug effects from PDDIs. Given the potentially severe consequences of incorrect drug information, there is a need for oversight to eliminate low quality and potentially harmful apps. Because managing PDDIs is complex in the absence of complete information, secondary features such as medication reminder, refill reminder, medication history tracking, and pill identification could help enhance the effectiveness of PDDI apps.
登录
查看更多内容
影响因子：
5.2
作者：
Baumel A;Muench F
通讯作者：
Muench F
DOI：
10.1331/japha.2013.12202
发表时间：
2013-03
期刊：
Journal of the American Pharmacists Association : JAPhA
影响因子：
--
作者：
Dayer L;Heldenbrand S;Anderson P;Gubbins PO;Martin BC
通讯作者：
Martin BC
影响因子：
3.7
作者：
Lindgaard, Gitte;Dudek, Cathy;Noonan, Patrick
通讯作者：
Noonan, Patrick
影响因子：
--
作者：
Becker, Matthijs L.;Caspers, Peter W. J.;Stricker, Bruno H. Ch.
通讯作者：
Stricker, Bruno H. Ch.
影响因子：
5
作者：
Kim BY;Lee J
通讯作者：
Lee J